CRISPR Therapeutics
CRSP
#3175
Rank
$3.85 B
Marketcap
$45.20
Share price
-0.36%
Change (1 day)
4.98%
Change (1 year)

CRISPR Therapeutics (CRSP) Fails to deliver data

Key failure to deliver metrics for CRISPR Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for CRISPR Therapeutics (CRSP) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for CRISPR Therapeutics (CRSP) - since 2016

Volume in USD (price x number of shares), data since 2016

CRISPR Therapeutics (CRSP) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024$0.10 B-26.52%
2023$0.14 B1.4%
2022$0.14 B8.89%
2021$0.13 B22.76%
2020$0.10 B-2.51%
2019$0.11 B59.97%
2018$70.19 M265.26%
2017$19.21 M319.28%
2016$4.58 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3months) FTD volume (1 year) Country
$1.07 M$6.44 M๐Ÿ‡บ๐Ÿ‡ธ USA